chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A report has been received from a Health Professional concerning a patient, subject of unknown gender, who had been receiving FLUMIST. FLUMIST started on 11-Sep-2012. The patient experienced tested positive for flu A. The patient recovered from the event of tested positive for flu A on an unspecified date. The report was considered to be non-serious.
Sore Arm; Bleeding on the injection site immediately after injection; Rush of warmth from upper chest going to his head; A spontaneous report was received from a Consumer concerning a 72-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced little bleeding on the injection site immediately after injection, rush of warmth from upper chest going to his head and sore arm.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 28 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot batch: 042L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 28 Jan 2021, the patient experienced little bleeding on the injection site immediately after injection and rush of warmth from upper chest going to his head. On 29 Jan 2021, the patient experienced the events sore arm.  No lab data was provided.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was unknown.  On 28 Jan 2021 the outcome of events bleeding on the injection site immediately after injection and rush of warmth from upper chest going to his head- was resolved. The outcome of event-sore arm -was considered to be unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested
Pt anxious with first dose of vaccine. Pt rt Lightheadedness and dizziness while still in her 15min observation time. Pt transition onto a stryker with  initial vs as BP 115/64, HR 77, RR 20-24. Pt was emotional, 2nd vs at 1035 BP 12/, HR , RR 18-20. Pt was talking to staff and became unresponsive for 5sec. ER Rapid response call for assistance. 3rd vs 122/78, HR 80 Map 89. Pt transported to ED. From ED Note: Patient symptoms improved and discharged from ED with counseling and return parameters. Patient evaluated by behavorial health for anxiety with outpatient follow up referral.
This is a 32y.o. at 40w4d, dated by 9w4d u/s not equal to LMP.  Patient seen in L&D for IOL due to GHTN.  At present (irregular)CTX, (+) FM, (denies) LOF, (denies) VB. The patient was seen for a scheduled NST due to post dates at which time she was found to have multiple elevated blood pressures in the 150's/90's and fetal tachycardia. Induction was discussed with patient, however at that time she did not want to be induced and left AMA. Today, the patient reports that she had multiple elevated blood pressures today up into the 150's systolic. Also reports seeing stars but otherwise denies complaints including headache, RUQ pain, shortness of breath and chest pain.     Pt receives prenatal care at Ob/Gyn.    Pregnancy complicated by CHTN versus GHTN (suspect GHTN, pt had one elevation @ NOB visit but states she was anxious and no prior hx of elevated BP) and history of forceps delivery.   PRENATALS: O POS, GBS (neg), HIV (non reactive), HBsAg (non reactive), Rubella (immune), RPR (non reactive), GC/Chlam (neg)   FHTS: 140 bpm, moderate variability, + accels, no decels  TOCO: rare SVE: 1/30/-5 BSUS: cephalic, posterior grade 3 placenta, EFW 8 lbs 2 oz, MVP 7.10 cm Adequate Pelvis, pelvis proven to 8 lbs 8 oz
This spontaneous report as received from a other health professional refers to a patient of unknown age. On an unknown date the patient was vaccinated with VARIVAX, subcutaneous for prophylaxis. Concomitant therapies included sterile diluent. On an unknown date the patient experienced product storage error.
Given varicella vaccine on 12/9/99. Developed 2.5 cm circular, raised, red, tender patch around injection site.
After flu shot within min had facial drooping and gotten a little worse. Occ. Thursday Nov 17, 2005.
Leg swelling due to blood clot, right leg, 12-13 inches long, possibly in other leg as well but less severe as no swelling.  Pulmonary Embolism (blood clot in lung) in both lungs within a week of each other.
Pt recvd 3 doses of Engerix-B & the third was administered 30AUG91 & it was determined that pt had low titers;
Increased Heart rate; Massive headache; Fever; Joint Pain; A spontaneous report was received from a consumer concerning a 64-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events massive headache, fever/pyrexia, joint pain/arthralgia, increased heart rate/heart rate increased.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 19 Mar 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) in the left arm for prophylaxis of COVID-19 infection.  On 19 Mar 2021, the patient experienced the events massive headache, fever, joint pain, increased heart rate and he was not doing well.  Treatment details included unspecified cold and flu medicine and regular medicine.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events massive headache, fever, joint pain, increased heart rate was unknown.
Fatigue; headache; hot flashes; diarrhea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 35 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 01Apr2021 (Lot number: ER8737) at the age of 35 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: SYNTHROID; TOPIRAMATE. The following information was reported: FATIGUE (non-serious) with onset 02Apr2021, outcome "recovering", described as "Fatigue"; HEADACHE (non-serious) with onset 02Apr2021, outcome "recovering", described as "headache"; HOT FLUSH (non-serious) with onset 02Apr2021, outcome "recovering", described as "hot flashes"; DIARRHOEA (non-serious) with onset 02Apr2021, outcome "recovering", described as "diarrhea". Therapeutic measures were not taken as a result of fatigue, headache, hot flush, diarrhoea.  Additional Information: The patient did not patient receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient  was not diagnosed with COVID, prior to vaccination. The patient  had not  tested for COVID-19 since the vaccination.  No follow-up attempts are possible. No further information is expected.
Blood pressure approx. 180/110 mmhg; Tachycardia up to 140 bpm; Arm soreness; Dizziness; Weakness; Tingling sensation of both hands and feet; A spontaneous report was received on 24 Jan 2021 via the call center regarding a 40-year-old female patient who reported receiving the Moderna COVID-19 Vaccine (mRNA-1273) and experienced tachycardia up to 140 bpm, dizziness, weakness, tingling sensation of both hands and feet, hypertension approximately 180/110 and arm soreness.  The patient's medical history was not provided. The patient was allergic to Demerol. Concomitant medication included Vyvanse for (ADHD) attention deficit hyperactivity disorder.   On 23 Jan 2021, prior to the onset of the symptoms, the patient received her first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.   On 23 Jan 2021, the patient reported tachycardia up to 140 bpm, dizziness, weakness, tingling sensation of both hands and feet, hypertension approximately 180/110 and arm soreness (still evident). No treatment medication was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events tachycardia up to 140 bpm, dizziness, weakness, tingling sensation of both hands and feet, hypertension approximately 180/110 was resolved on 23 Jan 2021. The outcome of the event was arm soreness unknown.; Reporter's Comments: This case concerns a 40-year-old female patient with no provided medical history who received her first of two planned doses of mRNA-1273, and on the same day experienced non-serious unlisted events of tachycardia up to 140 bpm, dizziness, weakness, tingling sensation of both hands and feet, hypertension approximately 180/110 and arm soreness. Very limited information regarding the events has been provided at this time.  Based on temporal association between the use of the product and the onset of the events, a causal relationship cannot be excluded and the events are considered possibly related to the vaccine.
arrived via EMS from home, c/o SOB, Fever, loss of taste, Was COVID NEG on Monday, not getting any better, When EMS arrive pt  O2sat @ 60's in RA
After 1st dose of Moderna vaccine, patient started to experience dizziness and lightheadedness. At 0926 BP was 121/69 mmHg and HR was 75 bpm. At 0930 BP was stable and HR decreased to 64 bpm. Over the course of observation, the patients HR decreased to 40 bpm and she continued to state that she felt lightheaded. Patient was given apple juice and granola bar. After 20 minutes of observation, the patient was taken to the ED for further observation.
Information has been received from a healthcare worker referring to a 68 year old female patient. The patient's medical history and concurrent conditions were not provided. On an unknown date in November 2014, the patient was vaccinated with initial dose of ZOSTAVAX (lot# K003596, expiration date unspecified, dose, route not provided). On 12-FEB-2016, she inadvertently administered a second dose of ZOSTAVAX (lot # L029485, expiration date 06-NOV-2016, dose and route not provided). Concomitant therapies were not provided. Patient developed redness and soreness at the injection site in her right arm an unspecified amount of time after the second dose of ZOSTAVAX. The patient visited physician for seeking medical attention and there were no diagnostics studies lab performed. The outcome of events was unknown. Additional information has been requested.
09/07/22 presents to ED for "abnormal labs" "hypokalemia". PMHx of "HTN, HLD, GERD, metastatic gallbladder cancer"
Rash caused by simplex virus; Rash was red; Rash was itchy; Rash consisted of raised bump/ elevation of bumps; This case was reported by a consumer via call center representative and described the occurrence of herpes simplex in a 72-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 22nd January 2022, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced herpes simplex, red rash, itchy rash and papular rash. On an unknown date, the outcome of the herpes simplex, red rash, itchy rash and papular rash were recovering/resolving.   It was unknown if the reporter considered the herpes simplex, red rash, itchy rash and papular rash to be related to Shingrix.  Additional details were provided as follows: The patient received a dose of Shingrix in left arm and developed a rash across their chest, underneath both pectorals and above the stomach. The patient reported that  rash was red, itchy, and consisted of raised bumps. The patient reported that  dermatologist reported rash was caused by herpes simplex virus.  The patient reported rash was ongoing, but redness, itch, and elevation of bumps had improved. The reporter consented to follow-up.
Site of injection painful, itching and pain radiating up the neck area. As day progressed, extreme fatigue, head ache and symptoms of upper respiratory infection. Chest heaviness, ears aching, nasal discharge, and low grade fever.
Patient iss fully vaccinated and boosted. Covid positive test at home but PCR Covid negative in ER. + wheezing with dry cough, runny nose, body aches. CTA PE protocol chest/no PE.  Patient seen by psychiatrist in ER with plan of inpatient psych for bipolar with acute psychosis. D Dimer 539. Tachycardia. WBC 10.8. Pt on room air. The patient was not a candidate for any treatment, especially the patient was on room air. discharged home
Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Became responsive after fainting-Mild, Systemic: Weakness-Mild, Additional Details: Patient loss consciousness and hit his head on the bottom shelf of the aisle, witnessed by a customer stating, "he fell and seizing."  Patient was assessed by the immunizer nurse. Per nurse's assesment, patient denied headache, shortness of breath, chest tightness, and visual changes. Patient was able to answer questions. Blood pressure was checked 128/85 with pulse of 102, O2 sat 94%. Blood sugar 99 mg/dL, taken by EMS.  Patient was observed for additional 30 mins.
At 1256 patient received the vaccine and went to the observation area to sit down. At 1257 patient fell to the floor in the observation area. Patient reported feeling dizzy and lightheaded. Patient was alert and oriented to person, place and time. Patient seemed confused about the situation. Patient appeared pale. Patient denied chest pain, head pain, and back pain. Patient reported pain only in the left arm at the injection site. The arm was assessed and it did not appear to be red or swollen. The patient denied any shortness of breath and denied any difficulty breathing. Patient denied any itching. Patient was kept laying down. At 1259 EMS/911 was called. At 1300 patient's BP 90/52 and HR 94 At 1302 patient's BP 88/62 and HR 88. Patient's legs were elevated. At 1305 patient's BP 88/60 and HR 81. At 1309 patient's BP 98/60 and HR 72. At 1310 the fire department arrived at the scene and assumed care of the patient. At 1316 patient's BP 118/77 and HR 78 while sitting. Patient's BP 122/81 and HR 89 while standing. Patient was transferred to a cot and was put in a sitting position. Patient reported some dizziness. At 1321 BP 92/63, HR 72, and O2 Sat 100%. At 1323 Patient refused offer to call family. Patient chose to call his girlfriend on his own. Patient was advised to go to the emergency room with the paramedics to prevent further worsening of his condition. At 1330 patient's BP 96/64, HR 69, and O2 Sat 99%. At 1332 Paramedics arrived on site and assumed care of the patient. Patient was transported to the nearest emergency room by ambulance.
Starting in the afternoon after my shot I started feeling extremely cold. I had chills and my teeth were actually chattering at one point it was so bad. This gradually got worse as the evening went on. With it I also started feeling weak and fatigued. By 8pm I started to have a headache. Throughout the night symptoms worsened and I had a fever and more serious headache. My head was pounding so badly. I couldn't sleep at all. I also had a couple hot flashes to where I woke up sweating. Then I would feel frozen again. The nausea started during the night too. I thought I would throw up but didn't. At one point my heart was racing so fast I was a little concerned something bad would happen to me and contemplated going to the hospital. By morning I felt a little better, still nauseous and with a bad headache. My body was a little weak. These symptoms lasted all day Thursday. By that Friday morning I only had a little weakness and slight headache. By mid day Friday I was pretty much back to normal.
Fever, Diarrhea, body aches, swelling, redness, and pain from shoulder to elbow of (L) arm.
Information has been from an unspecified healthcare worker from an office of the physician via a field representative concerning a female patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were unknown. On an unknown date, the patient received PNEUMOVAX 23 injection (lot # expiry date, dose and route not provided). On an unknown date, the patient experienced adverse event and was taken to the emergency room. The nature of the adverse event could not be confirmed as of the time of this report. It could not be confirmed if the patient was still in the emergency room at the time of this report. It also could not be confirmed if the adverse event was life threatening or if any extraordinary means, such as oxygen or cardiopulmonary resuscitation (CPR), were necessary because of the adverse event. The outcome and causality of the adverse event was unknown. Additional information has been requested.
Patient states she got her flu shot about 2 weeks ago but her arm is still in a lot of pain. Her arm is not red or swollen.
Patient reported redness, swelling, paiin, and fever after getting a flu and pneumonia shot in the left arm.
Took vaccine and was monitored for 30 minutes.  She left the area and went on to her duties.  Approximately 1 hour later, she reports noticing a hot flushing sensation starting at the top of her head.  It gradually was  going down to include her face and back upper body.  She notice splotching of her skin large half dollars size on her front of her body.  Smaller red spots on the back.  There was a clear line of demarcation at her breast line around to her back.  No SOB or respiratory issues.  Went home and took a 50 mg. Benedryl.  The  rash has lightened at this time 16:32 PM same day of vaccine.
My speech started getting impaired/slurred speech and I have a weakness in my right hand. I report it to my PCP and my Cardiologists an I ask to be referred to a Neurologist. I saw the Neurologist a month ago. They said that they have had several people to report the same thing. I don't know what has caused this. I just think it should be reported and investigated. All of this started happening to me after receiving the vaccine. I believe that it is a connection to all of my medical problems is from the vaccine. I didn't have any of this until I started getting the vaccine. With each of the vaccines, was a different problem. They referred me to a speech therapist. The therapist stated that I have Dysarthria Dysphasia.
she is recovering from Mono and her IGG levels are sky high; This is a spontaneous report received from contactable reporter(s) (Physician) from medical information team for a Pfizer sponsored program.  A 18 year-old female patient received bnt162b2 (BNT162B2), administered in deltoid right, administration date 05Apr2021 (Lot number: ER8734) at the age of 17 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (First dose, lot: EN6199, NDC: unknown , Expiration: unknown , route of administration: Right deltoid), administration date: 08Mar2021, when the patient was 17 years old, for Covid-19 immunization. The following information was reported: INFECTIOUS MONONUCLEOSIS (non-serious) with onset Oct2021, outcome "recovering", described as "she is recovering from Mono and her IGG levels are sky high". The event "she is recovering from mono and her igg levels are sky high" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Patient did not received any additional vaccines on Same Date of the Pfizer Suspect. Patient did not received prior vaccinations (within 4 weeks).  No follow-up attempts are possible. No further information is expected.
Dizziness, Headache, Nausea for 6 days, Vomiting for 1 day
POTENTIAL ADMINISTRATION ERROR /ADMINISTRATION OF AN EXPIRED VACCINE; TEMPERATURE EXCURSION (INCORRECT PRODUCT STORAGE); This spontaneous report received from a physician concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, and expiry: 23-JUN-2021) dose was not reported, administered on 07-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-JUN-2021, the subject experienced potential administration error /administration of an expired vaccine. On 07-JUN-2021, the subject experienced temperature excursion (incorrect product storage). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the potential administration error /administration of an expired vaccine and temperature excursion (incorrect product storage) was not reported. This report was non-serious. This case, from the same reporter is linked to 20210616693, 20210616952 and 20210617048.
Patient with significant swelling to right arm also is itchy, and warm to touch. Symptoms started on 10/13 while at school, he was sent home early. Patient seen in the office same afternoon, no n/v/d/ no SOB. No fevers. Patient was able to move arm well. No rash or reaction anywhere else on body.
Information has been received from a physician referring to an unspecified numbers of patients of unknown age and gender. There was no information about the patients' medical history and concurrent condition. On unknown dates, these patients were vaccinated with improperly stored doses of GARDASIL 9 (lot # L020015 with expiration date on 16-AUG-2017, dose and route unknown) (incorrect product storage). No adverse effects were reported. No product quality complaint was filed. Additional information has been requested.
This spontaneous report was received from a healthcare worker regarding an approximately 13-year-old female patient. On 31-AUG-2012, the patient was vaccinated with dose 1, 0.5 milliliter (ml) GARDASIL (lot# not reported) intramuscularly. No concomitant medications were reported. On 14-SEP-2012 the patient was vaccinated with her second dose of 0.5 ml GARDASIL (lot # not reported) intramuscularly. No adverse effects reported. No other information provided. Additional information is not expected.
PT WAS VACCINATED AT A POP UP CLINIC RAN BY HEALTH DEPT AT HER PLACE OF DWELLING--THE JOB CENTER AFTER BEING TOLD SHE WOULD HAVE TO QUARANTINE EVERY TIME SHE LEFT AND RETURNED TO HER DORM UNLESS SHE RECEIVED VACCINE. WITHIN 6 HOURS SHE EXPERIENCED INTENSE MUSCULAR PAIN AND HEADACHE. THIS PERSISTED AND INCREASED IN INTENSITY SUCH THAT SHE COULD NOT GET OUT OF BED DUE TO THE PAIN. ON ARRIVAL TO ER SHE HAD A TEMP OF 102 AND COMPLAINED OF MYALGIAS AND FATIGUE. DYSESTHESIA OF SKIN.
lt local neurotic pain, hypesthesia in deltoid to mid upper arm; gradually resolved 20JUN95
I had facial numbness (upper lip , nose and che) that started ~2 hrs after the injection and continued for several hours.
Headache, Myalgia, Fever, CoughWheeze, malaise, congestion Narrative: